Galapagos
Logotype for Galapagos NV

Galapagos (GLPG) investor relations material

Galapagos Q4 2025 earnings summary

Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.
Logotype for Galapagos NV
Q4 2025 earnings summary24 Feb, 2026

Executive summary

  • 2025 marked a strategic transformation, shifting focus from cell therapy to business development and long-term value creation, supported by a new leadership team and board with deep M&A and biopharma experience.

  • Collaboration with Gilead remains a key strategic advantage, providing deal flexibility and supporting capital allocation.

  • Leaner organization targeted, with 35–40 employees by end of 2026, maintaining key locations in Belgium and the US.

Financial highlights

  • Year-end 2025 cash and financial investments totaled €3.0 billion, with a decrease from €3,317.8 million at end-2024.

  • Total net revenues for 2025 were €1,112.2 million, up 304% year-over-year, mainly due to full recognition of €1,069 million deferred income from Gilead collaboration.

  • Operating profit from continuing operations was €295.1 million in 2025, reversing a loss of €188.3 million in 2024.

  • Net profit for 2025 was €320.9 million, up from €74.1 million in 2024.

  • R&D expenses rose 37% to €459.4 million, driven by cell therapy wind-down and early termination costs.

Outlook and guidance

  • Cell therapy wind down expected to be substantially completed by end of Q3 2026, with one-time restructuring cash impact of €125–175 million in 2026.

  • Additional €35–40 million in cash costs for final restructuring implementation in 2026.

  • Up to €40 million expected for ongoing TYK2 program and phase two clinical trials in 2026.

  • Anticipates being cash flow neutral to positive by year-end 2026, with year-end cash forecasted between €2.775 and €2.85 billion, excluding major business development or currency effects.

Detail BD focus areas and asset selection
Given the DM results, what is the GLPG3667 strategy?
How will the Gilead OLCA impact future revenues?
How does Gilead's support expand BD deal size?
What is the preferred path for GLPG3667?
How does 2026 cash flow neutrality impact BD?
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
Research faster. Power your platform.

Next Galapagos earnings date

Logotype for Galapagos NV
Q1 20267 May, 2026
Galapagos
Your earnings 
season toolkit.
Download
Free on both iOS & Android.

Next Galapagos earnings date

Logotype for Galapagos NV
Q1 20267 May, 2026

The essential earnings season companion

The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.

Live calls and transcripts

Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.

Find what you need faster

Search for any keyword across all transcripts simultaneously.

Easily store key findings

Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Your watchlist. Your dashboard.

Follow the companies that matter to you. Get a personalized feed with real-time updates.

Be the first to know

Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.

Consensus estimates

Access analyst consensus estimates, valuation multiples, and revenue segments splits.

All IR material in one place

The easiest way to stay updated during earnings season.

Global coverage

All events from public companies. Live and recorded.

Just click and listen

No webcast links. No manual registrations.

Research anytime, anywhere

Built for professionals. Loved by everyone. Try our free mobile app.

excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com

Frequently asked questions

Galapagos NV is a clinical-stage biotechnology company specialized in the discovery and development of small molecule medicines with novel modes of action. Our pipeline comprises four Phase 2 programs, three Phase 1 trials, five pre-clinical studies, and 20 discovery small-molecule and antibody programs in cystic fibrosis, inflammation, fibrosis, osteoarthritis, and other indications. Galapagos NV was founded in 1999 and is headquartered in Mechelen, Belgium.

Quartr provides global coverage of all investor relation material from public companies.

  • Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.

  • Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.

  • Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.

Yes, the Quartr mobile app is free on both iOS and Android.

Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.

Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.

Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.

Explore our global coverage